[This corrects the article DOI: 10.1371/journal.pone.0168312.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5305245 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0172404 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
Publication bias in pharmacogenetics of statin-associated muscle symptoms: A meta-epidemiological study.
Atherosclerosis
January 2025
Laboratoire de Biométrie et Biologie Evolutive UMR CNRS 5558, Université Lyon 1, Université de Lyon, Villeurbanne, France; Service Hospitalo-Universitaire de Pharmacotoxicologie, Pôle Santé Publique, Hospices Civils de Lyon, Lyon, France.
Background And Aims: Statin-associated muscle symptoms (SAMS) are a major cause of treatment discontinuation. Clinical Pharmacogenetics Implementation Consortium (CPIC) recommend dose adjustment for statin treatment according to known SLCO1B1 genotype to reduce SAMS. We hypothesized that the association between SLCO1B1 genotype and SAMS is misestimated because of publication bias.
View Article and Find Full Text PDFThe associations between modifiable risk factors and constipation: a comprehensive mendelian randomization study.
BMC Gastroenterol
October 2024
Department of Gastroenterology, the First Hospital of Lanzhou University, Lanzhou, China.
Objective: Early identification of modifiable risk factors is crucial for the prevention of constipation. This study systematically investigated the relationship between genetically predicted modifiable risk factors and constipation.
Methods: The inverse variance weighting (IVW) method was employed as the primary analytical approach.
Corrigendum: Effect of a high dose atorvastatin as added-on therapy on symptoms and serum AMPK/NLRP3 inflammasome and IL-6/STAT3 axes in patients with major depressive disorder: randomized controlled clinical study.
Front Pharmacol
August 2024
Department of Clinical Pharmacy, Faculty of Pharmacy, Menoufia University, Shebin El-Kom, Menoufia, Egypt.
Article Synopsis
- The text discusses a correction to a previously published article in the journal Pharmacology.
- The correction specifically addresses errors in the original study, ensuring accurate representation of the research findings.
- This update is important for maintaining the integrity of scientific literature and providing clear information to readers.
Effects of in utero benzo[a]pyrene exposure on the testis of rats during puberty and the protective effect of atorvastatin.
J Biochem Mol Toxicol
September 2024
Department of Anatomy, Faculty of Medicine, Molecular and Cell Biology Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
Benzo[a]pyrene (BaP) is a contaminant that is generated in the environment through processes such as smoke, incomplete combustion of fossil fuels, vehicle exhaust emissions, entry into the body is through inhalation, and consumption of contaminated food. It is an omnipresent environmental pollutant with unavoidable exposure. BaP metabolites are observed in the male reproductive system, especially in the testes and epididymis of animals, and are responsible for reduced testicular and epididymal function.
View Article and Find Full Text PDFCorrigendum: PCSK9i promoting the transformation of AS plaques into a stable plaque by targeting the miR-186-5p/Wipf2 and miR-375-3p/Pdk1/Yap1 in ApoE-/- mice.
Front Med (Lausanne)
June 2024
Department of Cardiology, The Second Hospital of Jilin University, Changchun, Jilin, China.
[This corrects the article DOI: 10.3389/fmed.2024.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!